Real-time enrollment status for this primary hyperoxaluria type 1 clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:22 AM UTC
| NCT Number | NCT07587021 |
| Recruiting Status | Recruiting |
| Condition | Primary Hyperoxaluria Type 1 |
| Phase | PHASE2 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | YolTech Therapeutics Co., Ltd |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT07587021 is currently recruiting participants. This phase2 study for primary hyperoxaluria type 1 is actively seeking new participants at 1 location across the United States. The study is sponsored by YolTech Therapeutics Co., Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07587021 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07587021 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.